Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shutting of PPAR-γ and ReIA

Nature Immunology

Volumn 5, Issue 1, 2004, Pages 104-112

  Kelly, Denise ^a   Campbell, Jamie I ^a   King, Timothy P ^a   Grant, George ^a   Jansson, Emmelie A ^b   Coutts, Alistair G P ^a   Pettersson, Sven ^b   Conway, Shaun ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA;

ANAEROBIC BACTERIUM; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTEROIDES THETAIOTAOMICRON; CHRONIC INFLAMMATION; COMMENSALISM; CONTROLLED STUDY; DRUG DESIGN; DRUG TARGETING; GENE CONTROL; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; INTESTINE FLORA; MICROBIAL ATTENUATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; TARGET CELL;

ANIMALS; BACTEROIDES; CACO-2 CELLS; CYTOKINES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GASTROINTESTINAL TRACT; HELA CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS;

EID: 0347756655     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1018     Document Type: Article

References (43)

1. Sartor, R.B. The influence of normal microbial flora on the development of chronic inflammation. Res. Immunol. 148, 567-576 (1997).
2. Rembacken, B.J. et al. Non-pathogenic E. coli versus mesalazine for the treament of ulcerative colitis: a randomised trial. Lancet 354, 635-639 (1999)
3. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75, 263-274 (1993).
4. + T cells are important for the balance between protective and pathogenic T-cell immunity. J. Exp. Med. 179, 589-600 (1994).
5. Campieri, M. & Gionchetti, P. Probiotics in inflammatory bowel disease: new insight to pathogenesis or possible therapeutic alternative. Gastroenterol. 116, 1246-1249 (1999).
6. Marteau, P.R., de Vrese, M., Cellier, C.J. & Schrezenmeir, J. Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr. 73, 430S-436S (2001).
7. Cario, E. et al. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164, 966-972 (2000).
8. Cong, Y., Weaver, C.T., Lazenby, A. & Elson, C.O. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169, 6112-6119 (2002).
9. Neish, A.S. et al. Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289, 1560-1563 (2000).
10. Kelly, D. & Conway, S. Genomics at work: the global gene response to enteric bacteria. Gut 49, 612-613 (2001).
11. McCormick, B.A., Colgan, S.P., Delp-Archer, C., Miller, S.I. & Madara, J.L. Salmonella typhimurium attachment to human intestinal epithelial monolayers: transcellular signalling to subepithelial neutrophils. J. Cell Biol. 123, 895-907 (1993).
12. Hang, L. et al. Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract. J. Immunol. 162, 3037-3044(1999).
13. Ghosh, S., May, M.J. & Kopp, E.B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260 (1998).
14. May, M.J. & Ghosh, S. Signal transduction through NF-κB. Immunol. Today 19, 80-88 (1998).
15. Schesser, K. et al. The YopJ locus is required for Yersinia-mediated inhibition of NF-κB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol. Microbiol. 28, 1067-1079 (1998).
16. Cheng, Q. et al. NF-κB subunit-specific regulation of the IκBα promoter. J. Biol. Chem. 269, 13551-13557 (1994).
17. Chiao, P.J., Miyamoto, S. & Verma, I.M. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci, USA 91, 28-32 (1994).
18. Haller, D. et al. TGFβ-1 inhibits non-pathogenic Gram negative bacteria-induced NF-κB recruitment to the IL-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. J. Biol. Chem. 278, 23851-23860 (2003).
19. Chen, L-f., Fischle, W., Verdin, E. & Greene, W.C. Duration of NF-κB action regulated by reversible acetylation. Science 293, 1653-1657 (2001).
20. Huang, T.T., Kudo, N., Yoshida, M. & Miyamoto, S. A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localisation of inactive NF-κB/IκBα complexes. Proc. Natl. Acad. Sci. USA 97, 1014-1019 (2000).
21. Kudo, H. et al. Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. USA 96, 9112-9117(1999).
22. Su, C.G. et al. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J. Clin. Invest. 104, 383-389 (1999).
23. Nakajima, A. et al. Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterol. 120, 460-469 (2001).
24. Wang, N. et al. Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J. Biol. Chem. 277, 34176-34181 (2002).
25. Katayama, K. et al. A novel PPARγ gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterol. 124, 1315-1324 (2003).
26. Chawla, K. et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7, 48-52 (2001).
27. Rossi, A. et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403, 103-108 (2000).
28. 2 inhibits multiple steps in the NF-κB signaling pathway. PNAS, 97, 4844-4849 (2000).
29. Bunn, C.F. et al. Nucleocytoplasmic shuttling of the thyroid hormone receptor α. Mol. Endocrinol. 15, 512-533 (2001).
30. Ricote, M., Huang, J.T., Welch, J.S. & Glass, C.K. The peroxisome proliferator-activated receptory (PPARγ) as a regulator of monocyte/macrophage function. J. Leukoc. Biol. 66, 733-739 (1999).
31. Chung, S.W. et al. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB. J. Biol. Chem. 275, 32681-32687 (2000).
32. Gurnell, M. et al. A dominant-negative peroxisome proliferator-activated receptor γ (PPARγ) mutant is a constitutive repressor and inhibits PPARγ-mediated adipogenesis. J. Biol. Chem. 275, 5754-5759 (2000).
33. Suzawa et al. Cytokines suppress adipogenesis and PPARγ function through the TAK1/TAB1/NIK cascade. Nature Cell Biol. 5, 224-230 (2003).
34. Schmid, J.A. et al. Dynamics of NF-κB and IκBα studied with green fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65 binding to DNA by fluorescence resonance energy transfer. J. Biol. Chem. 275, 17035-17042 (2000).
35. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81-S96 (2002).
36. Tam, W.F. & Sen, R. IκB family members function by different mechanisms. J. Biol. Chem. 276, 7701-7704 (2001).
37. Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
38. Sui, G. et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99, 5515-5520 (2002).
39. Gewirtz, A.T., Navas, T.A., Lyons, S., Godowski, P.J. & Madara, J.L. Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167, 1882-1885 (2001).
40. De Winter, H. et al. Regulation of mucosal immune responses by interleukin 10 produced by intestinal epithelial cells in mice. Gastroenterol. 122, 1829-1841 (2002).
41. Di Leo, V., Yang, P.C., Berin, M.C. & Perdue, M.H. Factors regulating the effect of IL-4 on intestinal epithelial barrier function. Int. Arch. Allergy Immunol. 129, 219-227 (2002).
42. Xu, J. et al. A genomic view of the human-Bacteroides, thetaiotaomicron symbosis. Science 299, 2074-2076 (2003).
43. Parkos, C.A., Delp, C., Arnaout, M.A. & Madara, J.L. Neutrophil migration across a cultured intestinal epithelium. Dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction. J. Clin. Invest. 88, 1605-1612 (1991).